We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Agfa Radiology

Guerbet

Offers products in medical imaging - diagnostic imaging, contrast media - contrast agents, MRI imaging, X Ray imaging... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Guerbet Showcases Comprehensive Range of Imaging Products, Solutions, and Services for Diagnostic Imaging at RSNA 2021

By MedImaging International staff writers
Posted on 30 Nov 2021
Print article
Illustration
Illustration

Guerbet LLC USA (Princeton, NJ, USA) showcased its comprehensive range of imaging products, solutions, and services for diagnostic imaging (MRI, CT, Cath Lab, Digital Solutions) at RSNA 2021.

Guerbet hosted live demo sessions of its digital solutions portfolio during RSNA 2021, including UNIK, a tailored solution for diagnostic imaging. UNIK is a flexible solution designed to create value by reflecting healthcare professionals' specific needs and improvement areas. By understanding customers' internal processes, Guerbet can provide an ecosystem of value by interconnecting its comprehensive portfolio of contrast media, injection solutions, digital solutions and technical support.

In addition to showcasing diagnostic and interventional solutions, Guerbet highlighted its OptiStar Elite MR contrast delivery system. The OptiStar Elite injector is part of Guerbet's Diagnostic Imaging UNIK portfolio. The OptiStar Elite MR contrast delivery system is a very simple, reliable MRI contrast media injector incorporating advanced performance features, thus reducing operating costs and improving patient throughput. It combines ease of use with multi-purpose functionality and high reliability offered by Guerbet.

Additionally, Guerbet highlighted Optiray (ioversol), a non-ionic monomeric, low osmolar iodinated contrast agent intended for intravascular administration. Depending on the indication, Optiray can be administered either by intravenous (IV) or intra-arterial route (IA). With its unique combination of ready-to-use presentation, wide range of concentrations, and appropriate physicochemical properties, Optiray helps you cover a large array of clinical situations, including the challenging ones.

Guerbet also highlighted OptiProtect 3S, its original suite of technical services and support designed to ensure and safeguard the lifetime of the company’s medical devices and digital solutions. Designed to protect the expected lifetime of its injection solutions, OptiProtect 3S can be tailored to address all types of challenges.

Related Links:
Guerbet LLC USA 


Print article

Channels

General/Advanced Imaging

view channel
Image: 3D cardiac map created with the EnSite X EP mapping system with OT (Photo courtesy of Abbott)

New Mapping System Improves Heart Rhythm Management

Thanks to omnipolar technology (OT), a new cardiac mapping system provides 360-degree views of the heart, regardless of catheter orientation. The Abbott (Abbott Park, IL, USA) EnSite X EP with OT system... Read more

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Illustration

Global Breast Imaging Systems Market to Reach USD 1.3 Billion by 2024 Due to COVID-19-Led Patient Backlog

The global breast imaging market is expected to be driven by rising incidences of breast cancer, coupled with the huge backlog of women requiring breast cancer screening appointments due to COVID-19.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.